Abstract:Low photoconversion efficiency and limited tissue penetration are the major barriers for photothermal therapy (PTT) agent application. Here, an efficient organic/inorganic dual‐PTT agent guided by MRI was proposed. It is proved the oxygen vacancy band narrowed its band gap that led to NIR‐II region absorb. Furthermore, the defect energy level trapping carrier and conjugate synergistic heat generation result in high photoconversion efficiency. Photothermal therapy (PTT), as an important noninvasive and effective tumor treatment method, has been extensively developed into a powerful cancer therapeutic technique. Nevertheless, the low photothermal conversion efficiency and the limited tissue penetration of typical photothermal therapeutic agents in the first near‐infrared (NIR‐I) region (700–950 nm) are still the major barriers for further clinical application. Here, we proposed an organic/inorganic dual‐PTT agent of synergistic property driven by polydopamine‐modified black‐titanium dioxide (b‐TiO2@PDA) with excellent photoconversion efficiency in the second NIR (NIR‐II) region (1000–1500 nm). More specifically, the b‐TiO2 treated with sodium borohydride produced excessive oxygen vacancies resulting in oxygen vacancy band that narrowed the b‐TiO2 band gap, and the small band gap led to NIR‐II region wavelength (1064 nm) absorbance. Furthermore, the combination of defect energy level trapping carrier recombination heat generation and conjugate heat generation mechanism, significantly improved the photothermal performance of the PTT agent based on b‐TiO2. The photothermal properties characterization indicated that the proposed dual‐PTT agent possesses excellent photothermal performance and ultra‐high photoconversion efficiency of 64.9% under 1064 nm laser irradiation, which can completely kill esophageal squamous cells. Meanwhile, Gd2O3 nanoparticles, an excellent magnetic resonance imaging (MRI) agent, were introduced into the nanosystem with similar dotted core–shell structure to enable the nanosystem achieve real‐time MRI‐monitored cancer therapeutic performance. We believe that this integrated nanotherapeutic system can not only solve the application of PTT in the NIR‐II region, but also provide certain theoretical guidance for the clinical diagnosis and treatment of esophageal cancer.

Insights into the deep-tissue photothermal therapy in near-infrared II region based on tumor-targeted MoO 2 nanoaggregates

Recent Progress on NIR-II Photothermal Therapy

Recent Advances in Photothermal Therapy at Near‐Infrared‐II Based on 2D MXenes

Multifunctional MoO2-ICG Nanoplatform for 808Nm-Mediated Synergetic Photodynamic/photothermal Therapy

Novel small molecule-based organic nanoparticles for second near-infrared photothermal tumor ablation

Metallic 1T Phase Enabling MoS 2 Nanodots as an Efficient Agent for Photoacoustic Imaging Guided Photothermal Therapy in the Near‐Infrared‐II Window

A novel activated NIR-II phototheranostic nanoagent and its application to photothermal therapy

Gd2O3/b‐TiO2 composite nanoprobes with ultra‐high photoconversion efficiency for MR image‐guided NIR‐II photothermal therapy

MoO3-x nanosheets-based platform for single NIR laser induced efficient PDT/PTT of cancer

A simple POM clusters for in vivo NIR-II photoacoustic imaging-guided NIR-II photothermal therapy

880 nm NIR-Triggered Organic Small Molecular-Based Nanoparticles for Photothermal Therapy of Tumor

Ultrathin carbon layer coated MoO2 nanoparticles for high-performance near-infrared photothermal cancer therapy

Near-Infrared IIb Emitting Nanoprobe for High-Resolution Real-Time Imaging-Guided Photothermal Therapy Triggering Enhanced Anti-tumor Immunity

Near-infrared-II Light Excitation Thermosensitive Liposomes for Photoacoustic Imaging-Guided Enhanced Photothermal-Chemo Synergistic Tumor Therapy

Organic nanomaterials for near-infrared light-triggered photothermal/thermodynamic combination therapy

Nano-materials for Image-guided Tumor Photo-thermal Therapy

NIR‐II Responsive Inorganic 2D Nanomaterials for Cancer Photothermal Therapy: Recent Advances and Future Challenges

J-aggregates of multi-groups cyanine dye for NIR-IIa fluorescence-guided mild photothermal therapy under 1064 nm irradiation

MoS 2 -based nanocomposites with high photothermal conversion efficiency for combinational photothermal/photodynamic tumor therapy

NIR‐II Absorption/Emission Dual‐Function‐Based 2D Targeted Nanotheranostics for Tunable Hydrogenothermal Therapy

High‐Performance NIR‐II Fluorescent Type I/II Photosensitizer Enabling Augmented Mild Photothermal Therapy of Tumors by Disrupting Heat Shock Proteins